2m 2m 2m 2m 2m 2m 2m
ADDEX THERAP SP ADS (ADXN)
NASDAQ
$6.04+$0.33 (+5.69%)
Price as of Jul 13, 2026 7:56 PM EDT- $8.0MMarket Cap
- -36.56%1-Year Change
- BiotechnologyIndustry
ADDEX THERAP SP ADS (ADXN)
$6.04+$0.33 (+5.69%)
ADXN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.71 | ||
Change | -$0.63 (-9.94%) | ||
Open | $5.84 | ||
High | $6.45 | ||
Low | $5.68 | ||
Previous Close | $6.34 | ||
Volume | 6,307 | ||
30-Day Average Volume | 4,690 | ||
1-Week Change | -1.38% | ||
1-Month Change | -11.47% | ||
1-Year Change | -36.56% | ||
3-Year Change | -53.58% | ||
5-Year Change | -96.99% | ||
Fundamentals | |||
Shares Outstanding | 1.3M | ||
Total Assets | $6.4M | ||
Market Cap | $8.0M | ||
Enterprise Value | $6.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/23/2023 | ||
Earnings & Revenue